Are Long Term Care Rebates Dangerous?
This article was originally published in RPM Report
One CMS official thinks it is time for a new business model in long term care. Eliminating rebates to long-term care providers may be necessary to protect patients and Part D plans.
You may also be interested in...
The battle between CVS and Express Scripts for ownership of Caremark has made little impact on drug-company executives. But there is an important implication for pricing in the Medicare Part D world: CVS wants to use Caremark to help it get higher payments for providing pharmacy services. But in the zero-sum game of reimbursement, any additional profits for chains will likely come from reduced prices on drugs.
Omnicare's lawsuit against UnitedHealth Group is part of a battle for survival by long-term care pharmacy providers. The stakes for manufacturers are high: who can really deliver market share under Part D?
Medicare drug plans and retail pharmacy groups are working together to clean up the mess that plagued the launch of Part D. The manufacturers should pay attention: the result may be new force in drug selection and adherence.